Practice Business

See final frame for AE reporting.

For HCPs in GB only.

Adverse events should be reported. Reporting forms and
information can be found at yellowcard.mhra.gov.uk.
Adverse events relating to CSL Seqirus products should also
be reported to Seqirus UK Limited on 01748 828816.

1. Seqirus Data on File, August 2023. SREF–17994.
2. Adjuvanted Trivalent Influenza Vaccine (surface antigen, inactivated)â–¼ Summary of Product Characteristics.
3. Cell-based Trivalent Influenza Vaccine (surface antigen, inactivated)â–¼ Summary of Product Characteristics.

Click for Prescribing Information

Click for Prescribing Information

GBR-AQIV-24-0062 | August 2024

  • Home
  • News
  • Sign Up
  • About
    • About Practice Business
    • Our Team
    • Contact us
    • For Advertisers
  • Sign in
  • Management
  • Health & Patient Care
  • Health Tech
  • Practice Operations
  • Recruit and Retain
  • Legal & Compliance
  • Live It
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow us on LinkedIn
  • Email us
HomePSIRF

PSIRF

Man and woman Health and safety advisors working together at the laptop, discussing H&S projects
Compliance

Enhancing patient safety through NHS Resolution’s learning service

December 6, 2023

In the complex landscape of healthcare, NHS Resolution’s Safety and Learning service emerges as a crucial ally, addressing risks, claims, and championing patient safety best keep reading

You may also enjoy

  • Supporting Employees in Mental Health Recovery
    January 30, 2025
  • NEWS: Patients Give Up on NHS Complaints
    January 30, 2025
  • Turn the Monday Blues into Monday Motivation
    January 29, 2025
  • Strategies for a Stress Free Practice Relocation
    January 29, 2025
  • NEWS: GPs Urged to Ask About Gambling
    January 29, 2025
  • Mastering Emotional Dynamics: Key Leadership Skills for 2025
    January 28, 2025
  • Read Again: The Controversy Surrounding GP Connect
    January 28, 2025
  • How Practice Managers Can Combat Low Morale
    January 27, 2025
About us

Our brand has evolved and grown over the past 11 years – today we are a market leading healthcare publisher who produce monthly publications, websites, events and other targeted information, specifically for practice managers, GP partners and the other decision makers responsible for practice management

About Us
ADVERTISE WITH US

We here at Practice Business pride ourselves in creating solutions for suppliers to deliver their message in the most effective and interesting way possible. Our long-standing experience means the end result will be on message and read by the right people, every time. Get in touch today to find out how you can better reach your audience.

Advertising Options
OUR SISTER SITES

Our broader portfolio also includes a rich mix of education management titles – for state schools and academies, independent fee paying schools and free schools – we have something for everyone!

Dealer Support
Education Executive
Contact us

Intelligent Media,
c/o Soho Works, Unit 4.1
The Tea Building
56 Shoreditch High Street London
E1 6JJ

Tel: 0203 794 8555
Fax: 0203 794 8554
Contact Us
Terms and Conditions
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow us on LinkedIn
  • Email us

Copyright © 2025 | Practice Business | Intelligent Media Solutions | This site is intended for healthcare professionals only.

See final frame for AE reporting.

For HCPs in GB only.

Adverse events should be reported. Reporting forms and
information can be found at yellowcard.mhra.gov.uk.
Adverse events relating to CSL Seqirus products should also
be reported to Seqirus UK Limited on 01748 828816.

1. Seqirus Data on File, August 2023. SREF–17994.
2. Adjuvanted Trivalent Influenza Vaccine (surface antigen, inactivated)â–¼ Summary of Product Characteristics.
3. Cell-based Trivalent Influenza Vaccine (surface antigen, inactivated)â–¼ Summary of Product Characteristics.

Click for Prescribing Information

GBR-AQIV-24-0065 | August 2024